Plasmodium vivax malaria after autologous bone marrow transplantation: an unusual complication

Bone Marrow Transplant. 1996 Oct;18(4):805-6.

Abstract

We report the case of unusually early infection by Plasmodium vivax after autologous bone marrow transplantation in a 20-year-old female from Bangladesh affected by acute myelogenous leukemia in first complete remission (CR) who underwent autologous bone marrow transplantation in our center. During the aplastic phase she became febrile; broad spectrum antibiotics and antifungal therapy were without effect. Blood smears were examined and Plasmodium vivax was detected despite a very low number of red cells infected. Cloroquine therapy for 3 days was given followed by primaquine for 2 weeks in order to avoid possible cloroquine resistance. Fever disappeared within 48 h from initial treatment and the patient was discharged having completely recovered at day +30. Primary malaria infection in non-endemic areas is a very rare event. In this particular case, after excluding primary infection or blood transfusion-mediated infection, malaria was attributed to a recrudescence of a primary unidentified infection.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antimalarials / therapeutic use
  • Bone Marrow Transplantation / adverse effects*
  • Chloroquine / therapeutic use
  • Female
  • Humans
  • Immunocompromised Host
  • Leukemia, Myelomonocytic, Acute / therapy
  • Malaria, Vivax / diagnosis
  • Malaria, Vivax / drug therapy
  • Malaria, Vivax / etiology*
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / etiology*
  • Transplantation, Autologous

Substances

  • Antimalarials
  • Chloroquine